Lallemand Health Solutions and dsm-firmenich have partnered to introduce groundbreaking synergistic synbiotic solutions, created through the fusion of human milk oligosaccharides (HMOs) with probiotics specifically designed for infant nutrition. This collaborative effort is focused on promoting the establishment of a microbiome in infants that closely mirrors that of breastfed babies, enhancing the development stage.
The offering combines HMOs, the third largest solid component of breast milk, and probiotics to nurture the development of the immune system, optimize the gut microbiome, and foster ideal developmental pathways.
HMOs also support the creation of beneficial gut bacteria, microbiota, and immune systems. Lallemand Health Solutions and dsm-firmenich hope to use their unique formulas to enhance infant health and development.
Image Credit: New Africa